Publication | Closed Access

Effects of Cholesterol-Lowering With Simvastatin on Stroke and Other Major Vascular Events in 20 536 People With Cerebrovascular Disease or Other High-Risk Conditions

ThrombosisVascular DiseaseIschemic StrokeCardiovascular DiseaseMedicineCerebrovascular DiseaseOther High-risk ConditionsHyperlipidemiaVascular BiologyDyslipidemiaNeurologyCerebral Blood FlowPublic HealthStrokeAtherosclerosisEpidemiology